Pink Sheet
Scrip
Medtech Insight
HBW Insight
Generics Bulletin
In Vivo
Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Appeals Court Rehearing Rejected In Teva-GSK Skinny-Label Saga
Split Federal Circuit Refuses ‘En Banc’ Rehearing Of Labeling Carve-Out Case
Feb 14 2022
•
By
Dave Wallace
The appeals court refused to rehear the case on labelling carve-outs
More from Legal & IP
More from Generics Bulletin